Asia Pacific HIV Diagnostics Market – Insights
HIV diagnostics plays a major role in HIV prevention, treatment, care, and other support services. The diagnosis of HIV includes testing services in health-care facilities, free-standing sites, and a wide range of community-based approaches along with HIV self-testing. Developments such as home testing represent new and major opportunities for addressing HIV among men who have sex with men (MSM). According to the UNAIDS, the Joint United Nations Program on HIV and AIDS, 2018 data, Asia Pacific recorded around 5.2 million people living with HIV in 2017.
The Asia Pacific HIV diagnostics market size was valued at US$ 301.1 million in 2017, and is expected to witness a CAGR of 12.3% over the forecast period (2018 – 2026).
Asia Pacific HIV Diagnostics Market Revenue (US$ Mn) Analysis, By Product Type, 2017
Source: Coherent Market Insights Analysis (2019)
Increasing Government Initiatives to Reduce HIV/AIDS Burden are Expected to Drive Asia Pacific HIV Diagnostics Market Revenue
Governments of various countries in Asia Pacific are taking initiatives to create awareness regarding HIV among people due to high prevalence of HIV/AIDS in the region. This in turn is increasing adoption of HIV diagnostic instruments and test kits. Low literacy rate coupled with unawareness regarding transmission mode on HIV, changing lifestyle, and unsafe sex are some of the factors leading to increasing number of HIV cases. In order to lower the disease incidence and increase life expectancy of infected patients, governments of various countries along with NGOs are focusing on improving HIV diagnostics and making them easily accessible to the general population.
In 2014, UNAIDS, the Joint United Nations Program on HIV and AIDS, is engaged in global efforts to end AIDS as a public health threat by 2030 and is a part of the UN Sustainable Development Goal. According to UNAIDS targets, by 2020, 90% of all people living with HIV will know HIV status and 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy. Furthermore, around US$ 3.7 billion was available in 2017 for the AIDS response in Asia Pacific, according to UNAIDS.
Asia Pacific HIV Diagnostics Market Restraints
Several variants of the virus are found worldwide and some variants tend to be more prevalent in certain geographies than others. Testing kits, when not designed to accommodate this variation, can provide incorrect results. Furthermore, inadequacy of competent healthcare personnel, unreliability of test results, and poor staff attitudes are other major factors driving patients away from HIV screening. For instance, in June 2017, Health Sciences Authority (HSA), Singapore; recalled 9 lots of HIV screening test kits, after it was found that the kits could result in false negative results for some people in the early stages of HIV infection. Furthermore, lack of awareness regarding testing procedures, inaccessibility to testing sites, inconvenient testing hours, and cost of testing are also negatively impacting Asia Pacific HIV diagnostics market growth.
Asia Pacific HIV Diagnostics Market - Country Insights
Asia Pacific HIV diagnostics market revenue is expected to foresee significant growth over the forecast period. The market in India is expected to be a major driver for Asia Pacific HIV diagnostics market growth, owing to high prevalence of HIV epidemic in India, with major cases concentrated among sex workers, homosexuals, people who inject drugs, and transgenders. For instance, according to Avert, 2.1 million people were suffering from HIV in 2017 in India.
Increasing HIV testing and counselling facilities in India is driving demand for HIV-based diagnostic products. For instance, according to National AIDS Control Organization’s (NACO) 2017-2018 annual report, the number of HIV testing and counselling sites in India increased from 67 in 1997, to around 23,400 facilities in 2017. Furthermore, between April 2016 and April 2017, around 18.6 million general users accessed these services, surpassing India’s annual testing target of 14 million.
Asia Pacific HIV Diagnostics Market Share 2017 (%), By Country
Source: Coherent Market Insights Analysis (2019)
Asia Pacific HIV Diagnostics Market - Competitive Landscape
Key players operating in the Asia Pacific HIV diagnostics market include, Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche AG, Atomo Diagnostics, Siemens Healthineers, Inc., bioLytical Laboratories Inc., MedMira Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Danaher Corporation.
Although the most efficient test results are obtained by Enzyme-Linked Immunosorbent Assay (ELISA) test initially and later by Western blot method, HIV diagnosis can be performed by blood test, saliva test, and viral load test. The ELISA test is an enzyme-linked immunosorbent assay and uses antibodies to identify the substance. The Western blot technique is used to detect anti –HIV antibodies in the human serum sample. According to WHO, the HIV diagnosis includes free –standing sites, testing services in health care facilities, some community-based approaches and HIV self-testing (HIVST).
Increasing engagement programs by various government bodies to reduce disease burden of HIV epidemics and growing need for safe blood transfusion and donations in Asia Pacific is expected to drive the HIV diagnostic market size during the forecast period. For instance, India plans to make Pre-exposure prophylaxis (PrEP) available to men who have sex with men (MSM) and transgender women. The Indian Council of Medical Research (ICMR) indicated in November 2018 that it is planning to study the effectiveness of PrEP in high-risk groups.
However, stigma and social ostracism associated with HIV infections and diseases is expected to hinder the timely HIV diagnostics and treatment. Moreover, the fear of being tested positive, discrimination, rejection, and stigma restricts several people from conducting screening voluntarily. The fear of discord in marital relationships is yet another challenge where testing HIV positive is often seen as a case of infidelity. Therefore, these factors are expected to hamper the market growth.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 22 market data tables and 14 figures on "Asia Pacific HIV Diagnostics Market” - Asia Pacific forecast to 2026”
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.